随着人类对疾病认识的不断深入,以证据为导向已成为医疗决策体系的重要一环。近年来,全球范围内临床研究取得的长足进步,特别是基于我国人群的高质量证据不断涌现,在国际舞台上崭露头角,这些都为健康管理提供了大量理论支撑;成像技术、干细胞重编程、癌症早期诊断等新技术进一步向临床应用转化;我国重大新药创制、精准医学研究、重大慢性非传染性疾病防控研究等科技重大专项的实施将我国临床研究引领至新高度;医疗大数据、移动医疗的兴起和发展,形成了医疗科技服务新业态;传统意义上的基础研究、应用研究、技术开发和产业化的边界已然日趋模糊,均为健康管理学科及相关产业发展提供了有力支撑,为健康管理和慢病健康管理提供了中国解决方案和手段。
<<With the continuous deepening of human awareness of disease,evidence-based medicine has become an important part of the medical decision-making system. In recent years,considerable clinical research has been made,especially the high quality evidence based on Chinese population. Imaging,stem cell reprogramming,cancer early diagnosis and other new technologies has further transform to clinical application. These evidence provides theoretical support for health management. The practice of numbers of national key project of drug research and development,precision medicine research and major chronic non communicable disease prevention will leading China’s clinical research to new heights;The development of medical big data,new mobile medical technology services have formed a new form of medical science and technology Service. The traditional sense of the basic research,clinical research,and technology industrialization has become blurred,and provided strong support for the health management and the related industries.
<<